# Flapless Application of Enamel Matrix Derivative in Class II Mandibular Furcation Defects

> **NCT05541614** · NA · UNKNOWN · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 44 (estimated)

## Conditions studied

- Periodontal Diseases
- Periodontal Disease, AVDC Stage 3
- Periodontal Disease, AVDC Stage 4
- Furcation Defects

## Interventions

- **OTHER:** Emdogain® FL (flapless Emdogain®) - Enamel Matrix Derivative
- **OTHER:** Emdogain® - Enamel Matrix Derivative

## Key facts

- **NCT ID:** NCT05541614
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-15
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05541614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05541614, "Flapless Application of Enamel Matrix Derivative in Class II Mandibular Furcation Defects". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT05541614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*